Brett Sandercock - 12 Jul 2021 Form 4 Insider Report for RESMED INC (RMD)

Role
Chief Financial Officer
Signature
Brett Sandercock, Chief Financial Officer
Issuer symbol
RMD
Transactions as of
12 Jul 2021
Net transactions value
-$621,150
Form type
4
Filing time
13 Jul 2021, 18:10:06 UTC
Previous filing
14 Jun 2021
Next filing
11 Aug 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RMD ResMed Common Stock Sale $621,150 -2,500 -2.8% $248.46 87,502 12 Jul 2021 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The transaction was conducted under a Rule 10b5-1 plan.